Nifedipine
Nifedipine · NIFEDIPINE 1 kg/kg · Powder · Shilpa Pharma Lifesciences Limited
NDC 82920-0502-03 · 1 BAG in 1 DRUM / 10 kg in 1 BAG · BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (bulk ingredient for human prescription compounding) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
ⓘ How this was built
- CMS NADAC weekly files (data.medicaid.gov), December 2024 onward
- CMS NADAC per-year archive files, 2013 – November 2024, averaged per month
- CMS Federal Upper Limit file — weighted average manufacturer price (WAMP) of the generic group (dashed line)
One line, two regimes: before December 2024 each point is the average of that month's archived NADAC rows for this NDC; from December 2024 each point is a row from the weekly file, which CMS publishes only when the price changes, so the line holds flat until the next change and is extended to today when the last row is under 6 months old. Since the December 2024 file CMS computes generic NADAC as a 3-month moving average, so recent generic moves are smoothed and lag the market. The dashed WAMP is the manufacturer-side average for the whole multiple-source group, not this NDC alone. To check a point: open the NADAC file for that date on data.medicaid.gov and find this NDC.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NDCs that have a NADAC price and a generic name.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
ⓘ How this was built
- FDA Orange Book data files — patent and exclusivity tables for application (none), edition retrieved 2026-08-24
Rows are the Orange Book's patent and exclusivity listings for this NDA, de-duplicated across product numbers (the file repeats a listing for every strength). A listed patent is a claim the sponsor filed; it may cover a use rather than the molecule, may be challenged, and may be delisted — a listing is not proof a generic is blocked. Pediatric extensions appear as *PED rows. FDA blocks automated downloads of the Orange Book from cloud servers, so the edition can trail FDA's monthly release; the retrieval date above is the edition shown. To check: search the application number on FDA's Orange Book site.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Shortage history
ⓘ How this was built
- FDA drug shortages via openFDA (current file: Current, To Be Discontinued, and recently Resolved rows)
- Internet Archive (Wayback) snapshots of FDA's shortage list since 2019, reconstructed into episodes
- DrugDashboards Kaplan–Meier duration curves and conditional duration model
Top rows are FDA's live listings whose package NDC is this product or another package of the same generic name and dosage form. openFDA drops resolved rows after about six months, so older episodes come from monthly Wayback snapshots of FDA's file, matched on the molecule with dosage-form words stripped (that matching can pull in other salts or forms of the same molecule — the presentation is shown so you can tell). 'Month N of a typical M' compares this episode's age with the Kaplan–Meier median for its form class (injectable, oral solid, other) over episodes since October 2019, open episodes censored; the resolution odds come from a model conditioned on the episode's age and reason. To check: FDA's drug shortage database, and web.archive.org for its history.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Not on FDA's current shortage list. Archived episodes below.
- Planned discontinuation — Pfizer Inc., PROCARDIA, CAPSULE, 10 mg (NDC 59762-1004-1) (listed as “NIFEDIPINE CAPSULE”)Dec 27, 2023 → last seen Nov 25, 2024
- Planned discontinuation — Pfizer Inc., Capsule, 10 mg (NDC 59762-1004-1) (listed as “Nifedipine Capsule”)Oct 26, 2023 → last seen Sep 29, 2024
- Planned discontinuation — Teva Pharmaceuticals, Nifedipine extended-release tablets, 90 mg, 500 count (NDC 45963-152-50) (listed as “Nifedipine Extended-Release Tablet, USP”)Jun 7, 2019 → last seen Nov 21, 2020
- Planned discontinuation — Teva Pharmaceuticals, Nifedipine extended-release tablets, 90 mg, 100 count (NDC 45963-152-02) (listed as “Nifedipine Extended-Release Tablet, USP”)Jun 7, 2019 → last seen Nov 21, 2020
- Planned discontinuation — Par Pharmaceutical, 60mg, 100 count bottle (NDC 10370-678-01) (listed as “Nifedipine Extended-Release Tablet, USP”)Apr 15, 2019 → last seen Nov 21, 2020
- Planned discontinuation — Par Pharmaceutical, 60mg, 500 count bottle (NDC 10370-678-05) (listed as “Nifedipine Extended-Release Tablet, USP”)Apr 15, 2019 → last seen Nov 21, 2020
- Planned discontinuation — Par Pharmaceutical, 90 mg, 100 count bottle (NDC 10370-679-01) (listed as “Nifedipine Extended-Release Tablet, USP”)Apr 15, 2019 → last seen Nov 21, 2020
- Planned discontinuation — Par Pharmaceutical, 30mg, 500 count bottle (NDC 10370-677-05) (listed as “Nifedipine Extended-Release Tablet, USP”)Apr 15, 2019 → last seen Nov 21, 2020
Showing 8 of 9 archived episodes.
Recalls (this NDC)
ⓘ How this was built
- FDA drug enforcement reports via openFDA
Enforcement reports whose product NDC list includes this exact package NDC, newest first, with FDA's classification (I = reasonable probability of serious harm, II = temporary or reversible harm, III = unlikely to cause harm) and the recall's current status. Reports for other packages of the same drug are not shown here; 275 of the last year's Class I/II reports carry no NDC at all and cannot be matched. To check: search the recall number on openFDA or FDA's enforcement reports.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No enforcement reports list this package NDC.
Labelers of Nifedipine (Powder)
15 labelers active in the last 30 days; 1not seen for 30+ days. Keyed on FDA's generic-name string — other salts or forms of the molecule are separate rosters.
ⓘ How this was built
- FDA NDC Directory (openFDA), read daily since 2026-07-15 — labeler_name per package
- DailyMed SPL establishment roles + name patterns → derived.labeler_kinds (repackager / manufacturer / unknown)
One row per labeler that lists any package with this exact generic-name string and dosage form; strengths are combined. 'First seen' is the first daily snapshot that contained the labeler here (2026-07-15 for everything present at the start), 'last seen' the most recent; a labeler counts as active when seen in the last 30 days. Repackagers and relabelers are flagged when their own labels show only repack/relabel operations or their name matches a known repackager, and are excluded from every 'makers' count on this page. Listing is not volume: a labeler with a listed NDC may ship little or nothing. To check: search the generic name in FDA's NDC Directory and list the labelers.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
| Labeler | Strengths | First seen | Last seen |
|---|---|---|---|
| Dipharma Francis Srl | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Sep 3, 2026 |
| Darmerica, Llc | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Sep 2, 2026 |
| Fagron Inc | NIFEDIPINE 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
| Kalchem International inc | NIFEDIPINE 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
| Letco Medical, Llc | NIFEDIPINE 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
| Medisca Inc. | NIFEDIPINE 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
| Moehs Catalana SL | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Sep 2, 2026 |
| Sharon Bio-Medicine Limited | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Sep 2, 2026 |
| SICOR Societa' Italiana Corticosteroidi s.r.l. | NIFEDIPINE 100 kg/100kg | Jul 15, 2026 | Sep 2, 2026 |
| Unique Chemicals | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Sep 2, 2026 |
| Viatris Pharmaceuticals LLC | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Sep 2, 2026 |
| Xenex Laboratories Inc | NIFEDIPINE 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
| F.I.S. Fabbrica Italiana Sintetici S.P.A. | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Aug 31, 2026 |
| Shilpa Pharma Lifesciences Limited | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Aug 31, 2026 |
| Professional Compounding Centers of America | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Aug 28, 2026 |
| Bayer AG | NIFEDIPINE 1 kg/kg | Jul 15, 2026 | Aug 5, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 15, 2026.
Cite this page
DrugDashboards, "Nifedipine — NDC 82920-0502-03," retrieved September 4, 2026, https://drugdashboards.com/drug/82920050203.
Free to cite with attribution — see how the data is put together.